FINWIRES · TerminalLIVE
FINWIRES

TMC Remains 'Underappreciated' After Advancing Permit Process for Critical Mineral Commercial Production, Wedbush Says

By

TMC the metals company (TMC) remains "underappreciated" even as the first mover in deep-seabed polymetallic nodule collection, Wedbush said in a Friday note.

The National Oceanic and Atmospheric Administration recently deemed the company's US unit's application for a seabed exploration license and commercial recovery permit fully compliant with federal law. The decision moves the application into the certification phase, after which it will be published for review, and a draft Environmental Impact Statement will follow for public comment before regulators make a final decision, according to the note.

With TMC anticipating to complete the regulatory process by Q1 of 2027, Wedbush analysts said it remains on track to start initial commercial production of critical minerals in the Clarion Clipperton Zone.

TMC continues to derisk its path to commercial production, the analysts said, noting the company's potential nodule processing hub in Brownsville, Texas, and expanding US government support.

Wedbush maintained the company's outperform rating and raised its price target to $10 from $8.

Price: $5.42, Change: $+0.18, Percent Change: +3.34%

Related Articles

Wire

Tanger Q1 Core FFO, Revenue Rise; 2026 Guidance Increased

Tanger (SKT) reported Q1 core funds from operations late Thursday of $0.59 per diluted share, up from $0.53 a year earlier.Analysts polled by FactSet expected $0.58.Revenue in the three months ended March 31 rose to $150.4 million from $135.4 million a year earlier.Analysts surveyed by FactSet expected $142.9 million.The company raised 2026 FFO guidance to $2.42 to $2.50 per diluted share from $2.41 to $2.49.Analysts polled by FactSet expect $2.47.Tanger shares fell 2.3% in after-hours trading.

$SKT
Wire

Alignment Healthcare Swings to Q1 Profit, Revenue Rises; Shares Fall After Hours

Alignment Healthcare (ALHC) reported Q1 earnings late Thursday of $0.05 per diluted share, compared with the loss of $0.05 a year earlier.Analysts polled by FactSet expected earnings of $0.01.Revenue in the three months ended March 31 rose to $1.24 billion from $926.9 million a year ago.Analysts surveyed by FactSet expected $1.22 billion.The company expects revenue of $1.3 billion to $1.32 billion in Q2 and $5.16 billion to $5.21 billion in the full year.Analysts project $1.31 billion in Q2 and $5.17 billion in 2026.Alignment Healthcare shares fell 10% in after-hours trading.

$ALHC
Wire

GoDaddy Q1 Earnings, Revenue Rise; Shares Gain After Hours

GoDaddy (GDDY) reported Q1 earnings late Thursday of $1.60 per diluted share, up from $1.51 a year earlier.Analysts polled by FactSet expected $1.52.Revenue in the three months ended March 31 rose to $1.27 billion from $1.19 billion a year earlier.Analysts surveyed by FactSet expected $1.26 billion.The company expects Q2 revenue of $1.29 billion to $1.31 billion. Analysts surveyed by FactSet expect $1.29 billion.GoDaddy reaffirmed 2026 revenue guidance of $5.2 billion to $5.28 billion. Analysts surveyed by FactSet expect $5.24 billion.In Q1, the company repurchased 3 million shares for $279.7 million.GoDaddy shares rose 4.2% in after-hours trading.

$GDDY